Despite this, it has been suggested that current regulatory bodies have been ineffective in preventing deception of patients as many companies have re-labelled their drugs to avoid the new laws.
På trods af dette er det blevet hævdet, at den nuværende kontrol fra myndighedernes side har været ineffektiv i forhold til at forhindre, at patienter bliver bedraget, fordi mange firmaer genmærker deres produkter, for at undgå de nye regler.